These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34535300)

  • 1. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate for Bleeding Complications of Vitamin K Antagonists-The PROPER3 Randomized Clinical Trial.
    Abdoellakhan RA; Khorsand N; Ter Avest E; Lameijer H; Faber LM; Ypma PF; Nieuwenhuizen L; Veeger NJGM; Meijer K
    Ann Emerg Med; 2022 Jan; 79(1):20-30. PubMed ID: 34535300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic Efficacy and Safety of Weight-Based Versus Fixed-Dose 4F-PCC for Vitamin K Antagonist Reversal.
    Milkovits AE; Sugrue D; Faris J; Schad JL; McAllister KB
    J Pharm Pract; 2024 Oct; 37(5):1099-1106. PubMed ID: 38241183
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
    Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
    Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Evaluation of a Fixed-Dose 4-Factor Prothrombin Complex Concentrate Protocol for Urgent Vitamin K Antagonist Reversal.
    Bitonti MT; Rumbarger RL; Absher RK; Curran LM
    J Emerg Med; 2020 Feb; 58(2):324-329. PubMed ID: 31787372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis.
    Abdoellakhan RA; Miah IP; Khorsand N; Meijer K; Jellema K
    Neurocrit Care; 2017 Feb; 26(1):64-69. PubMed ID: 27052728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K Antagonist Reversal for Urgent Surgery Using 4-Factor Prothrombin Complex Concentrates: A Randomized Clinical Trial.
    Sarode R; Goldstein JN; Simonian G; Hinterberger D; Matveev D; Gareis M; Milling TJ
    JAMA Netw Open; 2024 Aug; 7(8):e2424758. PubMed ID: 39088218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.
    Goldstein JN; Refaai MA; Milling TJ; Lewis B; Goldberg-Alberts R; Hug BA; Sarode R
    Lancet; 2015 May; 385(9982):2077-87. PubMed ID: 25728933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
    Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
    Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies.
    Khorsand N; Veeger NJ; van Hest RM; Ypma PF; Heidt J; Meijer K
    Haematologica; 2012 Oct; 97(10):1501-6. PubMed ID: 22491734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3).
    Abdoellakhan RA; Khorsand N; Van Hest RM; Veeger N; Ter Avest E; Ypma PF; Faber LM; Meijer K
    BMJ Open; 2018 Mar; 8(3):e020764. PubMed ID: 29540424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal.
    Elsamadisi P; Cepeda MAG; Yankama T; Wong A; Tran Q; Eche IM
    Am J Cardiovasc Drugs; 2021 May; 21(3):355-361. PubMed ID: 33150496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy.
    Khorsand N; Kooistra HA; van Hest RM; Veeger NJ; Meijer K
    Thromb Res; 2015 Jan; 135(1):9-19. PubMed ID: 25480313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
    Schwebach AA; Waybright RA; Johnson TJ
    Pharmacotherapy; 2019 May; 39(5):599-608. PubMed ID: 30892733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fixed-dose versus variable-dose prothrombin complex concentrate for warfarin reversal.
    Bajdas H; Handzel M; Uttaro E; Jones CMC; Kokanovich K; Acquisto NM
    Thromb Res; 2022 Jun; 214():76-81. PubMed ID: 35512560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy.
    Khorsand N; Veeger NJ; Muller M; Overdiek JW; Huisman W; van Hest RM; Meijer K
    Transfus Med; 2011 Apr; 21(2):116-23. PubMed ID: 21073580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy.
    Sobrino Jiménez C; Romero-Garrido JA; García-Martín Á; Quintana-Díaz M; Jiménez-Vicente C; González-Del Valle L; Herrero Ambrosio A; Benedí-González J
    Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e66-e71. PubMed ID: 32591479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study.
    Kushimoto S; Fukuoka T; Kimura A; Toyoda K; Brainsky A; Harman A; Chung T; Yasaka M
    Int J Hematol; 2017 Dec; 106(6):777-786. PubMed ID: 28815410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.
    Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I
    Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.
    Sarode R
    Clin Lab Med; 2014 Sep; 34(3):613-21. PubMed ID: 25168946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.